Do heart failure trials need an end point committee?

American Heart Journal

Volumn 160, Issue 4, 2010, Pages 571-573

  Ghali, Jalal K ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUCINDOLOL; CANDESARTAN; ENALAPRIL; OMAPATRILAT;

ACCURACY; CLINICAL TRIAL; COHORT ANALYSIS; DEHYDRATION; EDITORIAL; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HEART VENTRICLE FUNCTION; HOSPITALIZATION; HUMAN; LUNG CANCER; PRIORITY JOURNAL; RELIABILITY; STROKE; TREATMENT OUTCOME; VASCULAR DISEASE; BIOASSAY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ENDPOINT DETERMINATION; HEART FAILURE; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 77957846478     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.07.005     Document Type: Editorial

References (10)

1. Pogue J., Walter S.D., and Yusuf S. Evaluating the benefit of event adjudication of cardiovascular outcomes in large simple RCTs Clinical Trials 6 2009 239 251
2. Carson P., Fiuzat M., O'Connor C., Anand I., and Plehn J. Determination of hospitalization type by investigator case report form or adjudication committee in a large heart failure clinical trial (β-Blocker Evaluation of Survival Trial [BEST]). Am Heart J 160 2010 649 654
3. Walter S.D., Cook D.J., and Guyatt G.H. Outcome assessment for clinical trials: how many adjudicators do we need? Controlled Clin Trials 8 1997 27 42
4. Packer M., Califf R.M., Konstam M.A. for the OVERTURE Study Group Comparison of omapatrilat and enalapril in patients with chronic heart failure The Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE) Circulation 106 2002 920 926
5. Yusuf S., Pfeffer M.A., and Swedbert K. (CHARM Investigators and Committees). Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial Lancet 362 2003 777 781
6. Dunlay S.M., Redfield M.M., and Weston S.A. Hospitalizations after heart failure diagnosis J Am Coll Cardiol 54 2009 1695 1702
7. The SOLVD Investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure N Engl J Med 325 1991 293 302
8. Cohn J.N., Johnson G., and Ziesche S. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure N Engl J Med 325 1991 303 310
9. Narang R., Cleland J.G.F., and Erhardt L. Mode of death in chronic heart failure. A request and proposition for more accurate classification Eur Heart J 1996 1390 1403
10. Gustafsson F., Atar D., and Pitt B. Maximizing scientific knowledge from randomized clinical trials Am Heart J 159 2010 937 943